(Q37019876)

English

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

autism spectrum disorder

0 references

0 references

1 reference

based on heuristic

inferred from title

Lawrence Scahill

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lisa M Sullivan

object named as

Lisa Sullivan

11

0 references

Evdokia Anagnostou

9

object named as

Evdokia Anagnostou

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

7

object named as

Eric Hollander

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Bryan H King

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Kimberly Dukes

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Craig L Donnelly

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Linmarie Sikich

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

James T McCracken

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Joel D Bregman

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Fay Robinson

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Deborah Hirtz

12

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

1 November 2013

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

JAMA Pediatrics

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

167

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1045-1052

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A systematic review of secretin for children with autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Predictors and Moderators of Treatment Outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Antidepressant drug effects and depression severity: a patient-level meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Medication Use Among Children with Autism Spectrum Disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Placebo effects in developmental disabilities: implications for research and practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Risperidone in children with autism and serious behavioral problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Effect of secretin on children with autism: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Varieties of repetitive behavior in autism: comparisons to mental retardation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Secretin and autism: a two-part clinical investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Improved social and language skills after secretin administration in patients with autistic spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

29 September 2017

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

27 June 2018

The use of psychedelic agents with autistic schizophrenic children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

27 June 2018

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

27 June 2018

Antidepressant-placebo differences in 16 clinical trials over 10 years at a single site: role of baseline severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

Risperidone in children with autism: randomized, placebo-controlled, double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

Multiple doses of secretin in the treatment of autism: a controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4913472

4 September 2018

Placebo Response and Antidepressant Clinical Trial Outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24061784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMAPEDIATRICS.2013.2698

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37019876&oldid=1473149244"